Nifedipine in Congenital Hyperinsulinism-A Case Report

被引:6
作者
Khawash, Papiya [1 ]
Hussain, Khalid [2 ]
Flanagan, Sarah E. [3 ]
Chatterjee, Sudip [1 ]
Basak, Dhananjoy [1 ]
机构
[1] Pk Clin, Clin Paediat & Neonatol, Kolkata, India
[2] Inst Child Hlth, Univ Coll, Dev Endocrinol Res Grp, Clin & Mol Genet Unit, London, England
[3] Univ Exeter, Fac Med, Inst Biomed & Clin Sci, Mol Genet, Exeter, Devon, England
关键词
Congenital hyperinsulinism; nifedipine; octreotide; continuous glucose monitoring sensor; GLUCOSE MONITORING-SYSTEM; INSULIN-SECRETION; HYPOGLYCEMIA; INFANCY; INHIBITION; MANAGEMENT; DIAGNOSIS; CHANNELS; THERAPY; CALCIUM;
D O I
10.4274/jcrpe.1978
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congenital hyperinsulinism (CHI) is the commonest cause of persistent hypoglycemia in neonates. Diazoxide is the first-line drug in its treatment, but the more severe cases are usually diazoxide-resistant. Recessive ABCC8 and KCNJ11 mutations are responsible for most (82%) of the severe diazoxide-unresponsive CHI. Oral nifedipine has been effective in isolated cases of CHI. Successful treatment of diazoxide-unresponsive CHI with a combination of octreotide and nifedipine has been reported in a single isolated case so far. We report here a case of diazoxide-resistant CHI due to homozygous ABCC8 nonsense mutation. In this case, hypoglycaemia uncontrolled by pancreatectomy and octreotide alone showed a good response to a combination of nifedipine and octreotide. Octreotide was tapered off by one year age and thereafter the child is euglycaemic on oral nifedipine alone. Continuous glucose monitoring sensor was used as an aid to monitor glycaemic control and was found to be a safe and reliable option reducing the number of needle-pricks in small children.
引用
收藏
页码:151 / 154
页数:4
相关论文
共 18 条
  • [11] Diagnosis and management of hyperinsulinaemic hypoglycaemia of infancy
    Hussain, Khalid
    [J]. HORMONE RESEARCH, 2008, 69 (01) : 2 - 13
  • [12] Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management
    Hussain, Khalid
    Blankenstein, Oliver
    De Lonlay, Pascale
    Christesen, Henrik T.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (07) : 568 - 570
  • [13] Congenital Hyperinsulinism and Glucose Hypersensitivity in Homozygous and Heterozygous Carriers of Kir6.2 (KCNJ11) Mutation V290M Mutation KATP Channel Inactivation Mechanism and Clinical Management
    Loechner, Karen J.
    Akrouh, Alejandro
    Kurata, Harley T.
    Dionisi-Vici, Carlo
    Maiorana, Arianna
    Pizzoferro, Milena
    Rufini, Vittoria
    de Goyet, Jean de Vile
    Colombo, Carlo
    Barbetti, Fabrizio
    Koster, Joseph C.
    Nichols, Colin G.
    [J]. DIABETES, 2011, 60 (01) : 209 - 217
  • [14] Characterization of voltage operated R-type Ca2+ channels in modulating somatostatin receptor subtype 2-and 3-dependent inhibition of insulin secretion from INS-1 cells
    Mergler, Stefan
    Singh, Vandana
    Groetzinger, Carsten
    Kaczmarek, Przemyslaw
    Wiedenmann, Bertram
    Strowski, Mathias Z.
    [J]. CELLULAR SIGNALLING, 2008, 20 (12) : 2286 - 2295
  • [15] Continuous glucose monitoring system for congenital hyperinsulinemia
    Saif, Md
    Kapoor, Akshay
    Kochar, I. P. S.
    Jindal, Radhika
    [J]. INDIAN PEDIATRICS, 2013, 50 (04) : 421 - 422
  • [16] Persistent hyperinsulinemic hypoglycemia of infancy - Successful therapy with nifedipine
    Shanbag P.
    Pathak A.
    Vaidya M.
    Shahid S.K.
    [J]. The Indian Journal of Pediatrics, 2002, 69 (3) : 271 - 272
  • [17] Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K plus channels
    Szollosi, A.
    Nenquin, M.
    Henquin, J. C.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (03) : 669 - 677
  • [18] Yorifuji Tohru, 2014, Ann Pediatr Endocrinol Metab, V19, P57, DOI 10.6065/apem.2014.19.2.57